Brought to you by:
Transcatheter arterialization of the deep veins: Comparative analysis probes whether emerging modality is worth pursuing
“We’re living in a new world order” when it comes to “no-option” chronic limb-threatening ischemia (CLTI) patients, says Anahita Dua, MD. In recent years, into this arena has stepped transcatheter arterialization of the deep veins (TADV), raising hopes of reducing…
Long-term VQI-VISION analysis sheds light on PVI versus bypass in aortoiliac occlusive disease
Today’s Plenary Session 4—Hosted in Great Hall A, First Floor from 10:45 a.m.–12 p.m.—will feature a presentation of five-year findings from the VQI-VISION database indicating that aortobifemoral bypass (ABF) remains a more durable long-term treatment option compared to endovascular intervention…
Drilling into controversies in field of asymptomatic severe carotid stenosis management
Some of the enduring controversies in the management of asymptomatic severe carotid stenosis will underpin an educational session set to take place today. The session tackles debate around the deployment of carotid revascularization strategies in both standard- and high-risk patient…
Speaking in code: How a decline in Medicare reimbursement affects vascular care
Concerns were raised yesterday’s Plenary Session 2 over the recent decline in Medicare reimbursement at a national level. Querying current figures, speakers revealed discrepancies which highlight the importance of accurate reporting to ensure sustainable provision for the future of vascular…
One-year TAMBE data highlight low mortality, importance of renal branch assessment
The four-branch Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE) device demonstrated low mortality at one year with renal artery occlusion being the predominant device-related event associated with small renal arteries and pararenal aneurysms. So concluded Mark A. Farber, MD, presenting the…
No power, no problem! VAM 2025 pivots as early-morning power outage delays meeting opening
The vascular surgery world is used to pivoting on a dime. So it was as VAM 2025 was about to commence yesterday morning, and power outage problems led to a delayed start to this year’s SVS annual meeting. “We talk…
Training smarter, not harder: Analysis finds no negative impact of reduced core surgical requirements
Since the 2018 Accreditation Council for Graduate Medical Education (ACGME) reduction of core surgical requirements from 24 to 18 months during integrated vascular surgery residency, vascular residents’ operative experience has been unaffected, suggesting improved training optimization and efficiency. This was…
Explore the future of vascular surgery at Touchpoint@VAM
Today, 2025 Vascular Annual Meeting (VAM) attendees are encouraged to engage in an eye-opening experience at Touchpoint@VAM for an interactive event that will showcase the latest advancements in vascular surgery technology. The event will be held on the host venue’s…
Next gen: Pair of sessions tailored for medical students lay out keys to the specialty
Medical students attending the 2025 Vascular Annual Meeting (VAM) will have two unique opportunities to deepen their understanding of vascular surgery through sessions designed specifically for their level of training. On Thursday, June 5, the Society for Vascular Surgery (SVS) will…
First-in-man results to show promise for robot-assisted HIFU in PAD treatment
Results of a first-in-human study of non-invasive, robotic-assisted high intensity focused ultrasound (HIFU) for the treatment of peripheral arterial disease (PAD), to be presented Friday morning, will show that the therapy appears to be safe and feasible for the treatment…